Background/Aims: The sodium-dependent bicarbonate transporter Slc4a8 (a.k.a NDCBE) mediates the co-transport of sodium and bicarbonate in exchange for chloride. It is abundantly detected in the brain, with low expression levels in the kidney. The cell distribution and subcellular localization of Slc4a8 in the kidney and its role in acid/base and electrolyte homeostasis has been the subject of conflicting reports. There are no conclusive localization or functional studies to pinpoint the location and demonstrate the function of Slc4a8 in the kidney. Methods: Molecular techniques, including RT-PCR and in situ hybridization, were performed on kidney sections and tagged epitopes were used to examine the membrane targeting of Slc4a8 in polarized kidney cells. Crispr/Cas9 was used to generate and examine Slc4a8 KO mice. Results: Zonal distribution and in situ hybridization studies showed very little expression for Slc4a8 (NDCBE) in the cortex or in cortical collecting ducts (CCD). Slc4a8 was predominantly detected in the outer and inner medullary collecting ducts (OMCD and IMCD), and was targeted to the basolateral membrane of osmotically tolerant MDCK cells. Slc4a8 KO mice did not show any abnormal salt or bicarbonate wasting under baseline conditions or in response to bicarbonate loading, salt restriction or furosemide-induced diuresis. Conclusion: Slc4a8 (NDCBE) is absent in the CCD and is predominantly localized on the basolateral membrane of medullary collecting duct cells. Further, Slc4a8 deletion does not cause significant acid base or electrolyte abnormalities in pathophysiologic states. Additional studies are needed to examine the role of Slc4a8 (NDCBE) in intracellular pH and volume regulation in medullary collecting duct cells.
Introduction
Systemic vascular volume regulation and acid-base homeostasis are accomplished through the reabsorption of filtered salt (NaCl) and secretion of acid or base equivalents in various nephron segments . The bulk of salt reabsorption occurs in the proximal tubule [1] [2] [3] [4] [5] [6] [7] [8] [9] followed by the thick ascending limb of Henle [10] [11] and the distal convoluted tubule (DCT) [12] [13] [14] . The collecting duct (CD) and the connecting tubule (CNT); however, play a critical role in electrolyte and acid base homeostasis by fine tuning the H + and HCO 3 -transport and electrolyte composition of urine [15] [16] [17] [18] [19] [20] [21] [22] [23] . The sodium absorption in the CNT and cortical collecting duct (CCD) is predominantly mediated via the epithelial sodium channel, ENaC, in principal cells; whereas, chloride is absorbed via both transcellular and paracellular pathways [24] [25] [26] [27] [28] .
The transcellular absorption of chloride in CNT and CCD is primarily mediated via pendrin, an apical Cl − /HCO 3 -exchanger expressed in non A-intercalated cells and designated as SLC26A4 [16-20; 29-34] . Mice with the genetic deletion of pendrin or humans with inactivating mutations of the pendrin gene do not display excessive salt and fluid wasting or altered blood pressure under baseline conditions [33, 34] . Recent studies demonstrate that the Na-Cl cotransporter NCC (Slc12a3) and the Cl -/HCO 3 -exchanger pendrin (Slc26a4) crosscompensate for each other's loss of function, hence mitigating the magnitude of salt wasting in response to the inactivation/down-regulation of NCC or pendrin [35] [36] [37] [38] .
The SLC4A8 is a sodium-dependent bicarbonate transporter which was cloned based on homology to other NBCs, including SLC4A4 (a.k.a NBCe1; a.k.a. NBC1) [39] [40] [41] . It was originally given the designation of NBC-3 [39, 40] and subsequently renamed as NDCBE, consistent with functioning as a sodium-dependent Cl -/HCO 3 -exchanger [41] . In mice, Slc4a8 is abundantly detected in the brain, with very low expression levels in the kidney [39, 40, 42, 43, 44] .
Original studies on Slc4a8 (a.k.a NBC-3) in the kidney showed predominant expression in the medulla with low or no expression in the kidney cortex, and that it was sensitive to inhibition by stilbene DIDS in Oocytes [39, 40] . A more recent study reported a HCTZ (hydrochlorothiazide)-sensitive salt absorptive pathway in the CCDs of sodium-depleted mice that was attributed to Slc4a8 [45] . The authors proposed that Slc4a8 is located on the apical membrane of B-intercalated cells and collaborates with pendrin to facilitate the reabsorption of sodium and chloride in the collecting duct [45] . No localization studies (such as RT-PCR, immunohistochemical labeling and/or in situ hybridization) were utilized to demonstrate the localization of Slc4a8 in cortical collecting duct or, more specifically, in B-intercalated cells, and no functional studies were performed to directly pinpoint the location or demonstrate the function of Slc4a8 in the kidney. A follow up study comparing Slc4a8/NCC double KO mice vs. single NCC KO mice suggested that Slc4a8 may prevent the generation of hypokalemia in NCC KO mice by working in tandem with pendrin to claim the luminal salt in an ENaC-independent manner [46] .
To gain better insight into the cellular distribution, membrane targeting, and role of Slc4a8 (NDCBE) in the kidney, we performed a series of studies, including in situ hybridizations, membrane targeting in polarized kidney collecting duct cells, and generation and examination of Slc4a8 null mice. Our results demonstrate that Slc4a8 is completely absent in the cortex, including the CCD, and is primarily detected in medullary collecting duct cells. Slc4a8 null mice do not demonstrate any phenotypic salt wasting or acid base dysregulation in response to bicarbonate loading, salt restriction or furosemide-induced diuresis.
Materials and Methods

Expression of Slc4a8 in the kidney by RT-PCR
Mouse Slc4a8 has two distinct variants, with Variant 1 (gene accession number: NM_021530.2) being longer than variant 2 (gene accession number: NM_001347102.1) by 225 nucleotides and showing 50% homology within the next 83 nucleotides with Variant 2. The rest of the DNA sequence, which spans more than 11, 200 bp, is identical between the two variants. To examine the expression of Slc4a8 in mouse kidney, the following primers which are common to both variants were designed using the mouse Slc4a8 cDNA sequence (Genbank Accession number: NM_021530): ATCGGCACCACCGCACTCAT (sense) and AGCAGGGCTTCCCGCACTTT (antisense). The cycling parameters were 94 °C for 1 min, then 35 cycles at 94 °C for 30 s, and 68 °C for 1 mi. As indicated, the above DNA fragment encodes a sequence common to both variants of Slc4a8 (variants 1 and 2). The primers GCAGCTGTGCAAGGTGGATG (sense, specific for variant 2) and AGCAGGGCTTCCCGCACTTT (antisense) are specific for the N-terminal end of the shorter variant 2 (Genbank accession number: NM_001347102). The primers for the N-terminal end of slc4a8 variant 1 (gene bank accession number: nm_021530) are TCGCGGGCTGATGGCTATGAA(sense) and TTGTGCTGGTCCCACCC TGA(antisense).
The above primer pairs were used for RT-PCR on mouse kidney RNA isolated from cortex, outer medulla and inner medulla.
Expression of Slc4a8 by in situ hybridization
The PCR product of mouse Slc4a8 cDNA fragment, encoded by the primers ATCGGCACCACCGCACTCAT (sense) and AGCAGGGCTTCCCGCACTTT (antisense), was purified and ligated into a pGEM-T Easy Vector (Promega, Madison, WI). The plasmid was linearized using SacII and BstXI restriction enzymes for antisense and sense cRNA synthesizing, respectively. The antisense and sense cRNA probes were synthesized using DIG RNA Labeling Kit (SP6/T7) (Sigma Aldrich, St. Louis, MO). In situ hybridization experiments were performed on normal mouse brain and kidney sections using a in situ hybridization kit (Biochain, Newark, CA). Briefly, the paraffin slides were deparaffinized and rehydrated, fixed with 4% paraformaldehyde, treated with 10ug/ml proteinase K 15 minutes, subjected to pre-hybridization solution for 4 hours at 50⁰C, followed by treatment in hybridization solution with antisense or sense probe (3ng/ul) overnight at 55 0 C. Slides were washed with 2x, 1.5x and 0.2x SSC buffer, incubated with blocking solution for 1 hour at room temperature, incubated with 1:250 AP-conjugated anti-digoxingenin antibody over night at 4 o C, followed by NBT/BCIP incubation for 12 hours.
Cloning the full-length mouse Slc4a8
Full-length mouse Slc4a8 cDNA (long variant) was amplified from mouse kidney medulla RNA using the following PCR primers: 5′-TGGAACCTACCGGCGAGACC (sense) and 5′-TCCCGGAGAGACTCGCCATTT (antisense). These primers encode nucleotides 149 to 3537 of mouse Slc4a8 cDNA (GenBank accession number: NM_021530) and contain the entire open-reading frame. Amplification of mouse Slc4a8 cDNA by PCR was performed according to the Clontech Advantage-HF 2 PCR kit protocol (Clontech, Mountain View, CA). The PCR product was cloned into the GFP fusion TOPO vector (pcDNA3.1/NT-GFP-TOPO vector, Cat number:k481001). This resulted in the expression of GFP-tagged Slc4a8 protein with the GFP fusing to the N-terminus of Slc4a8. In parallel studies, the PCR product was ligated into the mammalian expression pTarget Vector (Promega, Madison, WI) for expression studies.
Cell culture and transfection procedures
For transient transfection studies, MDCK (Madin-Darby Canine Kidney) from ATCC (CRL 2936), were seeded on coverslips in a 24 wells plate 24-48 hrs before transfection, and were transfected at 70-90% confluence with 0.8 μg of full-length Slc4a8 cDNA construct by Lipofectamine 3000 (Thermo Fisher Scientific, Waltham, MA). Both GFP-tagged as well as a non tagged Slc4a8 full length cDNA were used. Twenty four (24) hrs after transfection, the medium was changed, with one group kept in normal medium and one group switched to a hypertonic medium (with 50 mmol/l NaCl) for incubation overnight. Cells were examined 48 h after transfection. The experiments for each maneuver were repeated at least 6 times. 
Confocal microscopic examination of Slc4a8
Transfected cells were washed and fixed in 4% formaldehyde-PBS solution as described [47, 48] . For co-labeling studies, MDCK cells were permeabilized with 0.1% Triton X-100 in PBS for 15 minutes. Two different set of studies were performed. In one set, the Slc4a8-GFP construct was used for transfection in MDCK cells. In separate studies, a non GFP Slc4a8 construct was used to transfect MDCK cells which were incubated with mouse anti-NDCBE antibodies (1:100) (Santa Cruz Biotechnology, Dallas, TX) at 4 o C overnight. Cells were switched to either a hypertonic medium or remained in isotonic medium 24 hrs later and fixed 48 h after transfection. All cells were co-labeled with Alexa Fluor 568 phalloidin (Molecular Probes, Eugene, OR) as a marker of apical membrane labeling. Images were taken on a Zeiss LSM710 confocal microscope. Both Z-line and Z-stack images were obtained using the LSM 5 Image software to analyze the membrane expression of Slc4a8 [47, 48] . All samples were repeated in triplicate for each experiment, and each experiment was repeated three independent times.
Generation of Slc4a8 KO mice by CRISPR/CAS9
Strategy. In order to knock out the Slc4a8 gene using the CRISPR system, two gRNAs that target the coding sequence of exon 3 and exon 4, respectively, were designed and injected along with Cas9 mRNA into cell embryos derived from mice of C57 background. The injections were performed at the Mouse Genome Facility, Children Hospital, University of Cincinnati. S1B ). The Slc4a8 KO mice are viable and grow normally.
Animal husbandry and experiments. Mice were cared for in accordance with protocols approved by the Institutional Animal Care and Use Committee (IACUC) at the University of Cincinnati and the VA Hospital. All animal handlers are IACUC trained. Animals had access to food and water ad libitum (unless subjected to a specific protocol), were housed in humidity-, temperature-, and light/dark-controlled rooms, and were inspected daily. Animals were euthanized with the use of excess anesthetics (0.150 ml euthazol per mouse) according to institutional guidelines and approved protocols.
Mice (WT: 5 animals: 3males/2females or KO: 5 animals: 3males/2 females) were placed in metabolic cages and after acclimation and were subjected to either bicarbonate loading for 4 days (140 mM NaHCO 3 Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry added to the drinking water), salt restriction (0.1% NaCl diet) for 6 days, or furosemide-induced diuresis (30mg/kg furosemide given ip once a day for 3 days). Five (5) animals placed in metabolic cages for the same duration were used as baseline. Urine pH and electrolyte excretion rate as well as serum electrolytes and acid base status were determined as described [37] . For dehydration, mice were subjected to water deprivation for 24 hrs with free access to food. This maneuver is associated with increased urine osmolality and enhanced medullary tonicity [49] . Four animals were subjected to water deprivation and compared to control group (n=4 per each group). Total RNA was isolated from medulla, resolved on a gel and probed with an Slc4a8 DNA fragment.
RNA isolation and Northern blot hybridization
Total cellular RNA was extracted from whole kidney, cortex, medulla, outer medulla and inner medulla according to established methods, quantitated spectrophotometrically, and stored at −80°C. Hybridization was performed according to established protocols. The following DNA fragments were used as specific probes for Northern blot hybridization: for Slc4a8, a fragment encoding nucleotides 362-833 from a mouse cDNA (accession number NM_021530); for Pendrin, a fragment corresponding to nucleotides 819-1509 from a mouse cDNA (accession number NM_011867), and for NCC, a DNA fragment spanning the nucleotides 481 to 959 of mouse NCC cDNA (Genebank # NM_001205311). For renin, a PCR fragment encoding nucleotides 291 to 600 (accession number NM_031192) and for AQP2, a fragment encoding nucleotides 102 to 397 (Accession number: BC128705.1) was used for the epithelial sodium channel, the following subunit specific nucleotide fragments were used: 750-1073 (GenBank accession no. NM_011324) for subunit α; 587-902(GenBank accession no. NM_011325) for subunit β; and nucleotides 621-1012(GenBank accession no. NM_011326) for subunit γ. Each Northern blot hybridization was performed on three separate samples from three different animals.
Western blotting
Plasma membrane protein were isolated from kidneys of WT and Slc4a8 KO mice, size-fractionated by SDS/PAGE (90 μg/lane), and blotted against pendrin or NCC antibodies according to established protocols [36, 37] . Pendrin antibodies for Western blotting were generous gifts from Dr. Peter Aronson (Yale University). NCC antibodies were purchased from StressMarq Biosciences (British Columbia, Canada). NCC phosphorylated antibodies were purchased from PhosphoSolutions (Aurora, CO). The loading per each lane was assessed by B-actin abundance.
Blood and urine electrolyte analysis
Mice were housed in metabolic cages and had free access to rodent chow and water. Food intake, water intake, and urine volume were measured daily. Urine was collected under mineral oil. Serum concentrations of Na
, and HCO 3 − were measured in blood with an i-STAT R -1 analyzer and i-STAT EG7+ cartridges (Abbott Laboratories, Abbott Park, IL).
Urine chloride and sodium concentrations were measured using an EasyLyte Plus Na/K/Cl analyzer (Medica, Bedford, MA). Serum concentration of Na 
Statistical analysis
Northern hybridization band densities were determined by densitometry with ImageQuaNT software (Molecular Dynamics, Sunnyvale, CA). The results are presented as means ± SE. Statistical significance between WT and pendrin KO mice was determined by Student's unpaired t-test, and P < 0.05 was considered significant.
Results
We first examined the expression of Slc4a8 by in situ hybridization. To test the specificity of the antisense probe, we first examined the expression of Slc4a8 in the brain, which is known to have a very high expression level for this transporter [42, 43] . Fig. 1C shows specific labeling of Slc4a8 in cerebellar Purkinje cell layer and in the choroid plexus. Fig. 2A depicts sense (left) and antisense (right) labeling in the kidney. As shown, Slc4a8 is specifically detected in the inner medulla in segments that resemble medullary collecting ducts (right). An analysis of Fig. 2A using Zeiss Zen 2012 image analysis software is shown in Fig. 2B , which shows the specificity of the antisense probe and demonstrates a highly significant Slc4a8 expression level in medullary collecting duct cells. Fig. 2C examines the expression of Slc4a8 in the cortex and medulla by Slc4a8 antisense labeling and clearly demonstrates significant expression levels in the medulla and its absence 
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Cellular Physiology and Biochemistry in the cortex. The above results demonstrate that Slc4a8 expression is primarily limited to the medulla, with predominant expression in medullary collecting duct cells.
To further determine the expression of Slc4a8, semi-quantitative RT-PCR was utilized to examine the expression of Slc4a8 in the cortex, outer medulla and inner medulla. As shown in Fig. 3A , using primers corresponding to the common domain of the cDNA encoding Slc4a8 (present in both variants 1 and 2), Slc4a8 exhibits significant expression in outer and inner medulla with no expression in the cortex. The expression of Slc4a8 in the heart [44] is shown for comparison. Using primers corresponding to the N-terminal region of the Slc4a8 variant 2 (absent in variant 1), a similar expression pattern of Slc4a8 was detected in the outer and . Slc4a8 is detected in outer and inner medulla with no expression in the cortex. The expression of Slc4a8 in the heart is shown for comparison. Fig. 3B is a semi-quantitative RT-PCR using primers corresponding to the N-terminal region of the Slc4a8 variant 2 (absent in variant 1). It shows a similar expression pattern of Slc4a8 in the outer and inner medulla, with no expression in the cortex (Fig. 3B) . Fig. 3C is a 40 cycle PCR and shows the absence of Slc4a8 in the cortex. For comparison, expression of OAT1 (Slc22a6) which is detected in both cortex and the whole kidney is shown. Fig. 3D presents a northern hybridization (left) and RT-PCR nephron distribution (right) of Slc4a8 in the brain and kidney. Slc4a8 signal is readily detected in the brain with lower levels in kidney medulla, specifically in the inner medulla, and no expression detected in the cortex. There was no evidence of enhanced expression of Slc4a8 in kidneys of NCC KO or pendrin KO mice (Fig. 3D) . (Fig. 3B) . The experiments in Fig. 3A and 3B use the standard 35 cycle PCR approach. Fig. 3C is a 40 cycle PCR and shows the detection of Slc4a8 in the whole kidney, but not in the cortex. For comparison, expression of OAT1 (Slc22a6) is detected in both cortex and the whole kidney. These results indicate that the expression of Slc4a8 in predominantly detected in the kidney medulla and demonstrates its complete absence in the cortex. Fig. 3D is a northern hybridization that shows the readily detected Slc4a8 mRNA signal in the brain with lower levels in kidney medulla and no expression in the cortex. There was no evidence indicating enhanced expression of Slc4a8 in kidneys of NCC KO or pendrin KO mice (Fig. 3D) . The mRNA expression levels for Slc4a8, when adjusted for the amount of loading using 28S rRNA levels, were 98 +/-7 and 110 +/-6 % in Pendrin KO and NCC KO, respectively, vs. control animals (p>0.05 vs. both models, n=4).
To determine its membrane targeting, Slc4a8 cDNA was epitope-tagged with the GFP and used to transfect the osmotically tolerant kidney MDCK cells. All cells were co-labeled with Alexa Fluor 568 phalloidin (Molecular Probes, Eugene, OR) as a marker of plasma membrane labeling. Cells were switched to either a hypertonic medium or remained in isotonic medium 24 hrs later and fixed 48 h after transfection. Fig. 4A shows that in the absence of 4A depicts the expression of GFP in MDCK cells. In the absence of Slc4a8 insert GFP signal is localized to the cytoplasm. Fig. 4B (top panels) illustrates the expression of Slc4a8 in MDCK cells in hypertonic medium. As shown, Slc4a8-GFP is targeted to the plasma membrane when merged images of GFP and phalloidin are acquired (front view or Z-stack image analysis in middle panel). The Slc4a8 is targeted to the basolateral membrane when the side view or Z-line images are acquired (Fig. 4B, bottom panel) . Fig. 4C illustrates the expression of Slc4a8 in MDCK cells transfected and maintained in isotonic medium. As indicated, Slc4a8 displays a sub-membrane localization in isotonic medium, when merged images of GFP and phalloidin are acquired (front view or Z-stack image analysis in middle panel). The GFP-tagged Slc4a8 remains in submembrane region when Z-line images were acquired (Fig.  4C, bottom panel) . The expression studies using GFP-tagged Slc4a8 construct were repeated 6 times in isotonic or hypertonic medium, which reproducibly showed the targeting of Slc4a8 to the basolateral membrane in hypertonic media. (Fig. 4B, bottom panel) . Fig.  4C illustrates the expression of Slc4a8 in MDCK cells in isotonic medium. As indicated, Slc4a8 predominantly shows sub-membrane localization in isotonic medium. These results indicate that Slc4a8 can function better in hypertonicity, an environment indigenous to the kidney medulla. The images acquired using a non GFP-tagged construct and a mouse Slc4a8 antibody exhibited a similar expression pattern but were not of the same sharp quality.
To determine the impact of Slc4a8 deletion on the expression of pendrin and NCC, northern and western hybridization studies were performed. Supplementary  Fig. S2A depicts northern and western hybridizations of pendrin in Slc4a8 KO mice. As indicate, the mRNA expression level (left panel) and protein abundance (right panel) of pendrin remained unchanged in Slc4a8 KO mice vs. WT mice (p>0.05, n=3). Supplementary Fig. S2B shows northern and western hybridizations of NCC (total and phosphorylated) and demonstrates comparable mRNA levels (left panel) and total and phosphorylated NCC abundance (right panel) in Slc4a8 KO mice vs. WT mice (p>0.05, n=3).
In the next series of experiments, we examined the role of Slc4a8 in systemic acid base homeostasis and vascular volume regulation by subjecting Slc4a8 KO mice to bicarbonate loading, sodium restriction or furosemide-induced diuresis. In the first series of experiments, we analyzed the effect of HCO 3 -loading (140 mEq/l of NaHCO 3 added to the drinking water) for 4 days on acid base and urine parameters in Slc4a8 KO mice. Body weights were -loading (140 mM NaHCO 3 added to the drinking water) on acid base and urine parameters in Slc4a8 KO mice was examined. Five (5) animals per each group (WT or KO) were subjected to bicarbonate loading or served as baseline. Urine pH, serum pH and acid base parameters were comparable in WT and Slc4a8 KO mice following 4 days of bicarbonate loading. Both genotypes showed comparable increases in urine pH in response to bicarbonate loading.
Cellular Physiology and Biochemistry comparable in both groups (average body weights in gm were 23.17 +/-1.69 for WT and 25.00 +/-1.01 for KO mice, p>0.05). As indicated in Fig. 5A -C, the urine pH, serum pH and acid base parameters were comparable in WT and Slc4a8 KO mice at baseline and following 4 days of bicarbonate loading. Both genotypes showed comparable increases in urine pH in response to bicarbonate loading. The next series of experiments examined the effect of salt restriction on salt excretion in WT and Slc4a8 KO mice. Animals (average body weights in gm were 24.10 +/-0.97 for WT vs. 24.76 +/-1.52 in Slc4a8 KO mice, p>0.05) were placed in metabolic cages and after acclimation were placed on a low sodium diet (0.1% sodium in liquid diet) for 6 days. As depicted in Fig. 6 , the urine sodium excretion rates dropped significantly and comparably in both genotypes. In addition, serum sodium and potassium concentration remained comparable in both genotypes (Fig. 6) .
In the next series of experiments, the effect of furosemide injection on urine volume was examined in WT and Slc4a8 KO mice following acclimation in metabolic cages. Average body weights in gm were 26.13 +/-1.52 for WT vs. 29.30 +/-1.68 in Slc4a8 KO mice, p>0.05. The magnitude of urine output in response to daily furosemide injection for 3 days was comparable in WT and Slc4a8 KO mice (Fig. 7) .
To examine the effect of enhanced tonicity of medulla on the expression of Slc4a8, animals (4 per each group) were subjected to water deprivation for 24 hrs (Methods). Medullary RNA (5) animals per each group (WT or KO) were subjected to salt restriction or served as baseline. As indicated in Fig.  6A , the urine sodium excretion rate dropped significantly and comparably in both genotypes after 6 days of salt restriction. In addition, systemic acid base parameters were comparable in both genotypes (Fig. 6B) . Serum K + concentrations remained comparable in WT and KO mice in response to salt restriction (p>0.05, n=5 per each group). (5) animals per each group (WT or KO) were injected with furosemide or served as baseline. As indicated, salt excretion rates were comparable in WT and Slc4a8 KO mice (Fig. 7) . Serum K + concentrations remained comparable in WT and KO mice in response to furosemide injection (p>0.05, n=5 per each group).
Cellular Physiology and Biochemistry was isolated and examined for the expression of Slc4a8. The results indicated a 44% increase in Slc4a8 expression levels in water deprived animals (p<0.05, n=4). A representative blot on Slc4a8 expression in water deprivation, using combined medulla of 2 animals, is depicted vs. control animals in Supplementary Fig. S3 .
Discussion
The present studies examine the expression and subcellular localization of Slc4a8 (NDCBE) in the kidney tubules. In situ hybridization studies were first conducted in the brain given the abundant neuronal expression of Slc4a8 based on published immunohistochemical studies [42, 43] . As indicated in Fig. 1 , Slc4a8 is abundantly detected in the hippocampal pyramidal cell layer and in the dentate gyrus. The background (sense labeling) was very minimal (Results). In addition, Slc4a8 is abundantly expressed in the cerebellar Purkinje cell layer and choroid plexus.
The localization pattern of Slc4a8 in situ signal in the kidney is strikingly limited to the medullary collecting duct and sharply drops at the edge of medulla and cortex (Fig. 2) . The results of the RT-PCR experiments demonstrate the predominant localization of Slc4a8 in the medullary region with a complete absence of expression in the kidney cortex, including the cortical collecting duct (CCD) (Fig. 3) . The expression in the medulla is detected in both the outer and inner sections, and is consistent with the presence of Slc4a8 in the medullary collecting duct, as observed by in situ hybridization.
The expression studies using GFP-tagged or wild type Slc4a8 cDNA in polarized kidney MDCK cells showed that Slc4a8 is localized to the plasma membrane and targeted to the basolateral membrane of osmotically tolerant kidney cells (Fig. 4B) . The targeting to the plasma membrane was predominantly observed in hypertonic medium (400 mOsm) (Fig.  4B) , whereas Slc4a8 was primarily detected in subapical or the cytoplasmic compartment in isotonic medium (300 mOsm). The side view of GFP-tagged images clearly showed the targeting of Slc4a8 to the basolateral membrane of MDCK cells (Fig. 4B, Bottom panel) . Taken together, these results demonstrate that Slc4a8 is localized to the basolateral membrane of medullary collecting duct cells. Whether Slc4a8 localizes to other medullary segments, such as the thin limb of Henle, could not be excluded by our studies.
Slc4a8 was originally named NBC-3, as it was the third NBC isoform to be cloned at the time [39, 40] . In the original studies, NBC-3 (later designated as Slc4a8 and renamed as NDCBE) was found to co-transport sodium and bicarbonate [40] . In separate studies, Slc4a8 was found to co-transport sodium and bicarbonate in exchange for intracellular chloride and it was renamed as NDCBE [41] . In the original studies, Slc4a8 (NBC-3) was predominantly detected in the kidney medulla [39, 40] . A study published recently suggested that Slc4a8 is located on the apical membrane of B-intercalated cells in the CCD [45] . However, no confirmatory RT-PCR, in situ hybridization or immunohistochemical staining have been published to support Slc4a8 expression in CCD or B-intercalated cells.
The report on HCTZ sensitivity of salt absorption in perfused CCD in sodium depleted mice was based on a combination of in vivo and in vitro studies [45] . The in vivo component demonstrated enhanced diuresis by HCTZ in NCC KO mice, which lack the known thiazide sensitive NCC [45] . The authors attributed the HCTZ-induced diuresis in NCC KO mice to the inhibition of Slc4a8 (NDCBE), based in part on the inhibition of net salt absorption in perfused CCD tubules by HCTZ but not amiloride [45] . The foremost argument against the HCTZ sensitivity of Slc4a8, however, is the complete resistance to HCTZ inhibition in Oocytes, even at the superphysiologic concentration of 1 mM [45] . Coupled with our expression studies (Results) we would like to propose that Slc4a8 is not expressed in the CCD, including the B-intercalated cells. Further support for the absence of Slc4a8 in the cortical collecting duct was reported in a recent study, which indicated that in single cell isolation of CCD cells (A-IC, B-IC and principal cells) Slc4a8 was not detected [31] . Given the complete absence of Slc4a8 mRNA in the CCD [31] , it is highly likely that the signal detected in western blots using . From a thermodynamic point of view, the parallel activation of pendrin and NHE-2 is equivalent to the coupling of an NBC-like pathway with pendrin, in that both pathways lead to enhanced entry of sodium and chloride in an electroneutral manner. It is worth mentioning that the amiloride concentration used in perfused tubules was only 10 -5 M (or 10 µmole); whereas, the concentration of HCTZ was 10 times higher (10 -4 M or 100 µmole) [44] . Given the relative resistance of NHE-2 to amiloride, we would like to suggest that enhanced electroneutral reabsorption of Na + and Cl -in NCC KO mice is likely mediated via NHE-2 and pendrin working in tandem, and a higher concentration of amiloride or an NHE-2 specific inhibitor (such as HOE694) would inhibit the electroneutral salt absorption in the distal nephron of NCC KO mice.
Conclusion
In conclusion, our studies demonstrate that Slc4a8 is absent in the kidney cortex, including cortical collecting duct, but is primarily expressed on the basolateral membrane of medullary collecting ducts. Slc4a8 KO mice do not exhibit any electrolyte or acid base abnormalities under baseline conditions or in response to bicarbonate loading, salt restriction or furosemide-induced diuresis. Whether Slc4a8 can play a role in intracellular pH and volume regulation in the medullary collecting duct in pathophysiologic states remains to be determined.
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